Skip to main content
Premium Trial:

Request an Annual Quote

Clear Labs Clear Safety Listeria, Environmental Mapping Testing

Menlo Park, California-based Clear Labs has launched new Listeria testing and environmental mapping capabilities on its Clear Safety next generation sequencing platform.

According to Clear Labs, Clear Safety now catalogs the genetic "fingerprint" of a Listeria sample and compares it to the fingerprints of Listeria previously encountered within a company. The platform can now detect, speciate, and characterize up to seven Listeria species ( monocytogenes, grayi, innocua, ivanovii marthii, seeligeri, and welshimeri) in a single analysis.

Clear Labs also noted that researchers can use the platform's similarity analysis to distinguish resident from transient subtypes of Listeria in the food manufacturing environment, which groups samples containing Listeria with matching fingerprints and tags them with metadata including location, date, and time. The firm's environmental mapping tool then overlays Listeria contamination on a facility map, allowing the team to track the flow of particular subtypes of Listeria through a facility over time. 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.